Adding perioperative COX-2 inhibition to maximal anti-nociceptive therapy had no impact on change in electric or pressure pain tolerance thresholds as a measure of central sensitization after breast cancer surgery. This evidence concerns the gene PTGS2 and breast carcinoma.